TY - JOUR
T1 - Management of dyslipidemia for cardiovascular disease risk reduction
T2 - Synopsis of the 2020 updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
AU - O'Malley, Patrick G.
AU - Arnold, Michael J.
AU - Kelley, Cathy
AU - Spacek, Lance
AU - Buelt, Andrew
AU - Natarajan, Sundar
AU - Donahue, Mark P.
AU - Vagichev, Elena
AU - Ballard-Hernandez, Jennifer
AU - Logan, Amanda
AU - Thomas, Lauren
AU - Ritter, Joan
AU - Neubauer, Brian E.
AU - Downs, John R.
N1 - Publisher Copyright:
© 2020 American College of Physicians. All rights reserved.
PY - 2020/11/17
Y1 - 2020/11/17
N2 - Description: In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. Methods: On 6 August to 9 August 2019, the VA/DoD Evidence- Based Practice Work Group (EBPWG) convened a joint VA/DoD guideline development effort that included clinical stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions, systematically searched and evaluated the literature (English-language publications from 1 December 2013 to 16 May 2019), and developed 27 recommendations and a simple 1-page algorithm. The recommendations were graded by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Recommendations: This synopsis summarizes key features of the guideline in 7 crucial areas: targeting of statin dose (not lowdensity lipoprotein cholesterol goals), additional tests for risk prediction, primary and secondary prevention, laboratory testing, physical activity, and nutrition.
AB - Description: In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. Methods: On 6 August to 9 August 2019, the VA/DoD Evidence- Based Practice Work Group (EBPWG) convened a joint VA/DoD guideline development effort that included clinical stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions, systematically searched and evaluated the literature (English-language publications from 1 December 2013 to 16 May 2019), and developed 27 recommendations and a simple 1-page algorithm. The recommendations were graded by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Recommendations: This synopsis summarizes key features of the guideline in 7 crucial areas: targeting of statin dose (not lowdensity lipoprotein cholesterol goals), additional tests for risk prediction, primary and secondary prevention, laboratory testing, physical activity, and nutrition.
UR - http://www.scopus.com/inward/record.url?scp=85096347603&partnerID=8YFLogxK
U2 - 10.7326/M20-4648
DO - 10.7326/M20-4648
M3 - Article
C2 - 32956597
AN - SCOPUS:85096347603
SN - 0003-4819
VL - 173
SP - 822
EP - 829
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
IS - 10
ER -